肺癌や悪性腫瘍 PD-L1高発現の進行非小細胞肺癌、ペムブロリズマブ単剤か化学療法併用か? PERSEE第III相試験
Descourt R, et al. Pembrolizumab with or without platinum-based chemotherapy as first-line treatment in advanced NSCLC expressing PD-L1 ≥50%: The PERSEE randomized phase III trial (GFPC 01-2020). Anna...